Cassava Sciences Announces Positive Results In Phase 2 Trial Of New Alzheimer’s Drug 0 14.09.2020 14:20 Forbes.com The drug, sumifilam, targets a new protein in Alzheimer’s disease called Filamen A. Партнёры Smi24.net Все новости за 24 часа Музыкальные новости Агрегатор новостей 24СМИ
